Page last updated: 2024-08-17

levodopa and Demyelinating Diseases

levodopa has been researched along with Demyelinating Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Frucht, S; Han, SC; Katus, L1
de Souza, A; de Souza, RJ1
Lim, SY; Ng, RX; Tan, AH1
Furtado, SV; Hegde, AS; Jagannatha, AT; Joshi, KC; Khanapure, KS; Perikal, PJ1
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H1
Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S1
Dufresne, JJ; Probst, A1
Hirano, F; Kimura, K; Makino, I; Narita, S1
Lal, A; Singh, S; Smith, BH1

Reviews

2 review(s) available for levodopa and Demyelinating Diseases

ArticleYear
Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
    World neurosurgery, 2018, Volume: 118

    Topics: Adenoma; Demyelinating Diseases; Female; Humans; Hydrocortisone; Hyponatremia; Hypopituitarism; Levodopa; Middle Aged; Myelinolysis, Central Pontine; Parkinsonian Disorders; Pituitary Neoplasms; Saline Solution, Hypertonic

2018
[A case of parkinsonism due to pontine and extrapontine myelinolysis].
    Rinsho shinkeigaku = Clinical neurology, 1992, Volume: 32, Issue:9

    Topics: Addison Disease; Adult; Brain Diseases; Demyelinating Diseases; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Pons; Tomography, X-Ray Computed

1992

Other Studies

7 other study(ies) available for levodopa and Demyelinating Diseases

ArticleYear
Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
    Tremor and other hyperkinetic movements (New York, N.Y.), 2020, 06-16, Volume: 10

    Topics: Adult; Antiparkinson Agents; Deamino Arginine Vasopressin; Demyelinating Diseases; Dystonia; Epistaxis; Hemostatics; Humans; Hyponatremia; Levodopa; Locked-In Syndrome; Male; Myelinolysis, Central Pontine; Osmotic Pressure; Parkinsonian Disorders; Postoperative Hemorrhage; Pramipexole; Pseudobulbar Palsy; Rhinoplasty; Tetrahydronaphthalenes; Thiophenes; Treatment Failure; Treatment Outcome; von Willebrand Disease, Type 1

2020
Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    Parkinsonism & related disorders, 2017, Volume: 43

    Topics: Aged; Antiparkinson Agents; Demyelinating Diseases; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Osmosis; Parkinsonian Disorders

2017
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
    JAMA neurology, 2018, 07-01, Volume: 75, Issue:7

    Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors

2018
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:2

    Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome

2006
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
    The Tohoku journal of experimental medicine, 2007, Volume: 211, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex

2007
[Supranuclear progressive paralysis (or oculo-facial-cervical dystonia)].
    Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1975, Volume: 116, Issue:1

    Topics: Aged; Bulbar Palsy, Progressive; Cerebral Cortex; Cranial Nerves; Demyelinating Diseases; Facial Paralysis; Female; Humans; Levodopa; Male; Middle Aged; Neck; Nerve Degeneration; Ophthalmoplegia; Reticular Formation

1975
Progressive supranuclear palsy (report of 4 cases with particular reference to blepharospasm and levodopa therapy).
    Neurology India, 1974, Volume: 22, Issue:2

    Topics: Aged; Bulbar Palsy, Progressive; Demyelinating Diseases; Eyelid Diseases; Female; Humans; Levodopa; Male; Middle Aged; Ophthalmoplegia; Spasm; Syndrome

1974